Entacapone promotes cAMP-dependent colonic Cl(-) secretion in rats

Area of Science:

• Gastroenterology
• Pharmacology
• Physiology

Background:

• Entacapone is a catechol-O-methyl transferase (COMT) inhibitor used for Parkinson's disease (PD).
• Entacapone is associated with gastrointestinal side effects.
• The mechanism underlying these side effects requires investigation.

Purpose of the Study:

• To investigate the effects of entacapone on epithelial ion transport in the rat distal colon.
• To elucidate the underlying molecular and neural mechanisms of entacapone-induced ion transport changes.

Main Methods:

• Short-circuit current (I(SC)) measurements on isolated rat colonic preparations (mucosa-only, submucosa-only, mucosa-submucosa).
• Scanning ion-selective electrode technique (SIET) for direct measurement of chloride (Cl(-)) flux.
• Radioimmunoassay (RIA) for intracellular cyclic adenosine monophosphate (cAMP) content determination.

Main Results:

• Entacapone significantly increased mucosal I(SC) and Cl(-) flux in the rat distal colon.
• Entacapone-induced I(SC) increases were dependent on cAMP, prostaglandins (PG), and the submucosal enteric nervous system (via tetrodotoxin (TTX) sensitivity).
• Entacapone elevated intracellular cAMP levels, an effect modulated by indomethacin and TTX.

Conclusions:

• Entacapone stimulates cAMP-dependent chloride secretion in the rat colon.
• Endogenous prostaglandins and the submucosal enteric nervous system play regulatory roles in entacapone's effects.
• These findings provide insights into the mechanisms of entacapone's gastrointestinal side effects.